What are the dominant trends in empty hard gelatin capsules, in India and globally?
As per the various research reports published recently the global empty gelatin capsule market was valued at $1841.5 million in 2017. It is showing a steady CAGR of 9.1 per cent from 2018 and is expected to reach a valuation of $3707.5 million by 2025.
India had a production a capacity of around 102 billion capsules in quantity in 2017-18. Roughly 40 per cent of this capacity is exported from India.
Tell us about the products you offer to India as well as international markets?
We have a total production capacity of eight billion capsules per year; which comes from Erawat Pharma and its group companies together. We are supplying our Indian and overseas clients with a very wide range of sizes to cater to almost all types of capsule dosages requirements. We are manufacturing capsules in size 00, 0el, 0, 1, 2, 3, 4, and 5. 00 being the biggest and size 5 being the smallest one. Depending on the customers’ requirements, these are then manufactured in various varieties suitable for dry powder inhalers, capsules filled with liquids, aesthetically attractive capsules, preservative-free capsules, etc., to name a few.
Then we have HPMC (popularly known as veg) capsules also in all sizes and varieties for specific customer requirements.
Your company has an established presence in the Indian market for 23 years, how do you plan to expand your international business?
We are working on a couple of target countries now and are establishing exclusive agents in these countries so that our reach is expanded. We are pretty selective on agents as well as countries because we want to maintain the quality of product and nurture relationships with our agents and customers. We also write our punch line, which is “looking forward to an ever-growing relationship” in all our communications and we truly believe in it.
We are also contemplating the possibilities of overseas manufacturing plants and are soon going to take a final decision on it after proper due diligence.
What are the newest market trends, determining and limiting factors? Also, tell us about the complexities and challenges associated with your company and products?
Continue reading your story on the app
Continue reading your story in the magazine
We might need to redefine our approach to drug discovery and approval to be prepared for the future
Hitesh Windlass, MD,Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his organisation’s plans for future growth and more, in an interview with Lakshmpriya Nair
We help our customers create future-ready pharma manufacturing and biotech facilities
Sanjay Sudhakaran, VP, Digital Energy, Schneider Electric India expands on the value proposition of digital energy systems for the pharma sector, giving some examples of how companies achieved RoI on this investment, in an interaction with Viveka Roychowdhury
Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials
Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the subsequent learnings in clinical research/trials, emerging trends in this arena and more, in an interaction with Viveka Roychowdhury
Waters Corporation appoints Pearl S Huang to Board of Directors
She has significant scientific expertise in the discovery of biologics, small molecule and nucleic acid-based therapies, as well as in drug discovery and the development of clinical trials
Fighting counterfeiting requires a long-term battle and we need to start somewhere
Globally, incidents of fake, counterfeit pharma products are on the rise and recent cyber attacks on some pharma companies involved in the development of COVID-19 vaccines are raising further alarm. Nakul Pasricha, President, Authentication Solution Providers’ Association (ASPA) talks about the need for a phygital approach to secure supply chain integrity and facilitate easy identification of genuine COVID-19 vaccines, with Usha Sharma
FDI in brownfield pharma projects - Critical analysis
Arvind Sharma, Partner, Shardul Amarchand Mangaldas & Co informs that the extant regulatory regime for FDI in brownfield projects follows a balanced approach as it safeguards supplies for domestic consumption and ensures foreign investments as well as technological advancement for the pharma sector
Effective effluent management: Key to tackle AMR
Dr Jyoti Joshi, Head-South Asia,The Center for Disease Dynamics, Economics & Policy (CDDEP); Adjunct Professor,Amity Institute of Public Health emphasises that the government and the pharma industry need to establish strategic partnerships to address the issue of growing AMR due to pharma plant effluents
CIMS Medica organises Business Excellence Awards 2020
The award ceremony was held at the The Leela Palace Hotel, New Delhi to honour companies who contributed to the growth and development of the healthcare and pharma industry
BLUEPRINT FOR PROGRESS
Experts and veterans examine and explore strategies for India Pharma Inc to implement the lessons learnt from the COVID-19 pandemic as we enter a new year and a new decade
Reverse Brain Drain: Accelerated By Covid-19
Ankit Goyal, Healthcare and Lifesciences Leader India, Heidrick & Struggles finds that leadership hiring is attracting ‘returnee Indians’ in healthcare companies due to growing opportunities in India, and more recently, the impact of the pandemic
YOGA & PEACE
DEEPAK CHOPRA speaks with DAAJI about the role Yoga has to play in bringing about world peace. This is an excerpt from their conversation broadcast on International Day of Peace, September 21, 2020. That documentary is available at https://heartfulness.org/en/international-day-of-peace/.
Create the habit of meditation
CHIRAG KULKARNI, Co-Founder and CMO of Medly Pharmacies in the USA, speaks with RISHIKA SHARMA about creating a regular meditation practice, so as to make it a habit. He also shares how meditation has benefited both his personal and professional life.
LiDAR MAPPING A GOLD MINE
When Consolidated Gold Mine in Dahlonega, Georgia, wanted to open more of its areas to public tours, they asked Inspired Intelligence, a family owned and operated drone business in Buford, Georgia, to help. Inspired Intelligence CEO and founder Nir Pe’er explained, “Besides drone technology, we also used new, amazing cutting-edge technology called LiDAR.
SHIA'S PRIVATE TEMPLE OF DOOM!
Indiana Jones gig derailed by abuse scandal
"Food Raconteur” Ashok Nageshwaran wants to tell you a story.
THE MAKING OF A MODEL MINORITY
Indian Americans rarely stop to ask why our entrance into American society has been so rapid—or to consider what we have in common with other nonwhite Americans.
In 2017, DR. VANDANA SHIVA spoke with KIM HUGHES about the sacredness of the Earth, the work she has been doing to bring awareness and change in the field of sustainable agriculture, and the importance of understanding our interconnectedness with Nature, and how we can change the way we eat.
How four master builders defined the path of the 2021 BMW R 18
DIAMONDS - A Luxury Gem Steeped in Fact & Fable
The diamond is one fabled gemstone! For example, google “Hope Diamond” to see all the legends associated with just this one stone said to bring misfortune to its owners.
Brown Sugaa and Medusa